| PERIOD ENDING | 30-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 583,400 | 1,280,000 | 960,100 | 318,000 | | Cost of Revenue | 423,700 | 793,200 | 601,800 | 233,800 | | | Gross Profit | 159,700 | 486,800 | 358,300 | 84,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 209,100 | 226,300 | 227,600 | 150,800 | | Non Recurring | (6,700) | 14,800 | (6,200) | 6,200 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (42,700) | 245,700 | 136,900 | (72,800) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (42,700) | 245,700 | 136,900 | (72,800) | | Interest Expense | 10,500 | 13,700 | 15,900 | 16,300 | | Income Before Tax | (53,200) | 232,000 | 121,000 | (89,100) | | Income Tax Expense | (38,300) | 84,200 | 43,600 | (32,100) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,900) | 147,800 | 77,400 | (57,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,900) | 147,800 | 77,400 | (57,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,900) | $147,800 | $77,400 | ($57,000) |
|
0.51% Nasdaq 
Income Statement
